Clinical Trials Browser

INDUSTRY × Sorafenib × Myeloid × Clear all

NCT00661180 2014-12-23

ORACLE

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive